(Q41230943)

28 September 2017

1 reference

title

Cardiovascular effects of oral hypoglycaemic drugs (English)

1 reference

28 September 2017

Howes LG

1

1 reference

28 September 2017

Sundaresan P

series ordinal

2

1 reference

28 September 2017

Lykos D

series ordinal

3

1 reference

28 September 2017

publication date

1 March 1996

1 reference

Clinical and Experimental Pharmacology and Physiology

28 September 2017

published in

1 reference

28 September 2017

volume

23

1 reference

28 September 2017

issue

3

1 reference

28 September 2017

page(s)

201-206

1 reference

Central role of sodium in hypertension in diabetic subjects

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Sulfonylureas and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Inotropic effects of tolbutamide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Glibenclamide, but not class III drugs, prevents ischaemic shortening of the refractory period in guinea-pig hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Plasma t-PA and PAI-1 Antigen Concentrations in Non-Insulin Dependent Diabetic Patients: Effects of Treatment Modality on Fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Studies on fibrin network structure in human plasma. Part II - Clinical application: Diabetes and antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

Treatment with low dose metformin in patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02596.X

10.1111/J.1440-1681.1996.TB02596.X

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference